Registration of the amendment to the Company's Articles of Association

Current Report No. 36/2022

Date of preparation: 16 September 2022

Subject: Registration of the amendment to the Company's Articles of Association

Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information

The Management Board of Captor Therapeutics S.A. based in Wrocław ("the Company") announces that on 16 September 2022 it became aware of the registration on 16 September 2022 by the District Court for Wrocław Fabryczna in Wrocław, 6th Commercial Division of the National Court Register of amendments to the Company's Articles of Association resulting from the resolutions of the Company's Ordinary General Meeting of 30 June 2022 (the "OGM") (attached to the Company's current report No. 25/2022 of 30 June 2022).

Pursuant to Resolution 14 of the OGM, the content of § 13.1 of the Company's Articles of Association was amended to read as follows:

"If the ManagementBoard consists of one person, the Company shall be represented by the sole member of the Management Board. If the Management Board consists of more than one person, the Company shall be represented by two members of the Management Board acting jointly."

Pursuant to Resolution No. 15 of the OGM, the content of § 6a(2)(2) of the Company's Articles of Association was amended, which acquired the following wording (extension of the duration of the Company's authorised capital):

"2) 30 June 2025 with respect to no more than 237,244 (two hundred and thirty-seven thousand two hundred and forty-four) shares issued under the Incentive Scheme (as defined below)."